About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Effect of MTX Discontinuation on Shingrix Response in RA

Effect of MTX Discontinuation on Shingrix Response in RA

NCT06574594·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Hong Ki Min, MD, PhD
CONTACT
+82-10-9977-5455 alsghdrl1921@naver.com

Lead

Konkuk University Medical Center

Age

19–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

fulfill 2010 ACR/EULAR classification criteria for rheumatoid arthritis
age over 19 years
methotrexate user
agree for vaccination with shingrix

You may not be if

have other form of inflammatory arthritis or autoimmune-mediated disease
malignancy, current infection, pregnancy

The record

StatusUnknown

PhaseNo phase

Taking part110

StartedAug 2024

UpdatedAug 28, 2024

Conditions

Rheumatoid Arthritis

Where1

Konkuk University Medical Center
Seoul, South Korea